215.39
2.43%
5.10
Handel nachbörslich:
215.39
Finanzdaten der Charles River Laboratories International Inc-Aktie (CRL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-30 | 2023-12-30 | 2023-09-30 | 2023-07-01 | 2023-04-01 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
0.19%
1,011.56
|
1,013.48 | 1,026.62 | 1,059.94 | 1,029.37 |
Cost Of Revenue |
666.72
|
- | - | - | - |
Gross Profit |
344.84
|
- | - | - | - |
Operating Expenses
|
75.14%
218.87
|
880.55 | 875.12 | 894.99 | 861.48 |
Interest Income/Expense |
4.34%
35.00
|
33.54 | 33.74 | 35.04 | 34.38 |
Benefits Costs and Expenses |
100.00%
-
|
3,548.12 | - | - | - |
Costs And Expenses |
3.38%
885.58
|
916.53 | 875.12 | 894.99 | 861.48 |
Operating Income/Loss |
5.22%
125.98
|
132.92 | 151.50 | 164.94 | 167.89 |
Income/Loss From Continuing Operations Before Tax |
139.91%
1,011.56
|
-2,534.65 | 1,026.62 | 1,059.94 | 1,029.37 |
Income Tax Expense/Benefit |
24.17%
24.53
|
19.75 | 24.85 | 29.22 | 27.09 |
Income/Loss From Continuing Operations After Tax |
60.58%
74.48
|
188.95 | 88.02 | 99.44 | 103.95 |
Net Income/Loss
|
60.58%
74.48
|
188.95 | 88.02 | 99.44 | 103.95 |
Preferred Stock Dividends And Other Adjustments |
5.631
|
- | - | - | - |
Attributable To Noncontrolling Interest |
18.52%
1.522
|
1.868 | 0.632 | 2.423 | 0.823 |
Basic Average Shares |
183.60K%
51.44
|
0.028 | 51.28 | 51.22 | 51.10 |
Diluted Average Shares |
123.53K%
51.84
|
-0.042 | 51.61 | 51.47 | 51.43 |
Basic Earnings Per Share |
64.11%
1.31
|
3.65 | 1.70 | 1.89 | 2.02 |
Diluted Earnings Per Share |
64.29%
1.30
|
3.64 | 1.69 | 1.89 | 2.01 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
5.631
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):